Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2035 of 5804
-
Should all preterm babies get extra nutrients? new study tests routine fortification
Disease control CompletedThe aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.
Phase: NA • Sponsor: Crouse Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Rheumatoid arthritis drug safety showdown: baricitinib vs. TNF inhibitors
Disease control CompletedThis post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
AI could predict which heart ablations work best
Knowledge-focused Recruiting nowAtrial fibrillation is a serious public health issue that affects over 5 million Americans (Miyazaka, Circulation 2006) in whom it may cause skipped beats, dizziness, stroke and even death. Therapy for AF is currently suboptimal, in part because AF represents several disease stat…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New autism program helps parents help kids in Low-Income areas
Symptom relief CompletedThe ASD Screening and Parent ENgagement (ASPEN) program is a culturally adapted, parent-mediated intervention program. The ASPEN program is tailored to address social communication and behavioral difficulties that young children with developmental delays may experience in early c…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Is waiting safe for AFib? new study tests delayed treatment
Disease control Recruiting nowThe AFFELECT -study compares two types of treatment modalities for acute atrial fibrillation or flutter for patients in whom rhythm control is desirable. The main purpose is to observe if these arrhythmias can be safely treated electively (within 5-9 days). All patients are recr…
Phase: NA • Sponsor: Tampere University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New tool could help Brain-Injured patients breathe on their own sooner
Knowledge-focused Recruiting nowThe BIPER study is a stepped wedge cluster randomised clinical trial aiming to decrease extubation failure in critically-ill brain-injured patients with residual impaired consciousness using a simple clinical score.
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Spine radiation study aims to cut fracture risk
Symptom relief Recruiting nowSpine radiosurgery (SRS) utilizes advanced treatment planning with focused x-rays to deliver one to four high dose treatments to the spine to help relieve pain and/or neurologic symptoms. Spine SRS uses special equipment to position the participant and guide the focused beams tow…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Glue vs. heat vs. knife: which vein fix wins?
Disease control TerminatedGlobal, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early and Advanced Stage Superficial Venous Disease
Phase: NA • Sponsor: Medtronic Endovascular • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Texts and talks in the ER boost child car safety
Disease control CompletedThis study involves an emergency department (ED)-based intervention utilizing Motivational Interviewing (MI) techniques and patient-centered eHealth materials (e.g., a tailored, mobile-friendly website and text messages) to promote the correct and consistent use of size-appropria…
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Heart attack recovery goes remote: video exercise may boost rehab attendance
Disease control OngoingThe overall aim of the study is to evaluate if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase participation in exCR sessions post myocardial infarction (MI).
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Sit down and stop leaks: new electromagnetic chair may cure incontinence
Disease control CompletedHigh intensity focused electromagnetic (HIFEM) technology induces deep pelvic floor muscle contractions designed to deliver the equivalent of 11,200 Kegel exercise over 28 minutes, with the intention of increasing neuromuscular tone of the pelvic floor. This study will have looki…
Phase: NA • Sponsor: Boston Urogynecology Associates • Aim: Disease control
Last updated Jun 26, 2026 13:37 UTC
-
New ultrasound technique could speed up kidney disease diagnosis in the ER
Diagnosis Recruiting nowChronic kidney disease is a common global public health issue and its prevalence increased year by year. Early diagnosis and intervention can prevent further complications and comorbidities of long-term dialysis, cardiovascular events and mortality as well as improve the patients…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Can magnetic pulses ease Schizophrenia's 'Negative' symptoms?
Symptom relief OngoingTreatment of depression with repetitive transcranial magnetic stimulation (rTMS) has shown high evidence using high-frequency left dorsolateral prefrontal cortex (DLPFC) stimulation. The treatment of negative symptoms with the same protocol in schizophrenia is considered as possi…
Phase: NA • Sponsor: University of Regensburg • Aim: Symptom relief
Last updated Jun 26, 2026 19:01 UTC
-
Tailored milk boosts preemie brain growth?
Disease control OngoingThis study is a randomized trial comparing 2 methods of human milk fortification for preterm infants in the neonatal intensive care unit (NICU). All participating infants will receive a human milk diet comprising maternal and/or donor milk plus multi-component and modular fortifi…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Massive pain trial aims to find new relief options
Symptom relief Recruiting nowThe purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions bec…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Prostate cancer drug darolutamide under Real-World microscope
Disease control OngoingThe purpose of this study is to find out in the real-world setting, if darolutamide is safe and effective for patients diagnosed with prostate cancer that has not spread to other parts of the body. When a patient is enrolled to the study, his/her physician would have already made…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill shows promise for controlling acromegaly Long-Term
Disease control OngoingA phase 2, open label, long-term extension study designed to evaluate the safety and efficacy of paltusotine (formerly CRN00808; an oral selective nonpeptide somatostatin receptor type 2 biased agonist) in subjects with acromegaly.
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Heart stent passes Real-World test: orsiro keeps arteries open
Disease control CompletedThe objective of this post-approval study is to confirm that the clinical performance of the Orsiro stent in a real-world setting is similar to the clinical performance observed for Orsiro in the BIOFLOW-V Investigational Device Exemption pivotal trial, as a condition of the US F…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Brain and body boost: could home-based cognitive and physical training ease 'chemo brain' after breast cancer?
Symptom relief CompletedInvestigator general objective is therefore to study and compare the benefit of several methods of management of cognitive difficulties reported by patients during treatment for breast cancer, among several treatments, offered independently in patients' homes and supervised from …
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Antibiotic vancomycin tested as PSC treatment – trial stopped early
Disease control TerminatedTo find out if vancomycin is a safe and effective therapy for primary sclerosing cholangitis. Funding Source - FDA OOPD
Phase: PHASE2, PHASE3 • Sponsor: Elizabeth Carey • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC